SEC reporting owner
| Reporting owner CIK | 0001866132 |
|---|---|
| Issuers | 2 |
| Qualifying disclosures | 28 |
| Public purchases | 0 |
| Recent-window purchases | 0 |
| Recent-window sales | 6 |
| Last public filing | 2026-09-08 |
| Coverage | verified |
| Directory rank | 13,709 |
| Publicly available | Trade date | Ticker | Code | Shares | Reported value |
|---|---|---|---|---|---|
| 2026-09-03 | 2026-09-01 | MRNA | S | 3,471 | Not reported |
| 2026-06-08 | 2026-06-04 | MRNA | S | 3,471 | Not reported |
| 2026-03-03 | 2026-03-02 | MRNA | S | 13,885 | Not reported |
| 2026-03-03 | 2026-03-01 | MRNA | A | 38,553 | Not reported |
| 2026-03-03 | 2026-03-01 | MRNA | A | 29,275 | Not reported |
| 2026-02-13 | 2026-02-11 | MRNA | A | 2,630 | Not reported |
| 2025-03-03 | 2025-03-01 | MRNA | A | 34,655 | Not reported |
| 2025-03-03 | 2025-03-01 | MRNA | A | 55,543 | Not reported |
| 2025-02-14 | 2025-02-12 | MRNA | A | 2,047 | Not reported |
| 2024-12-10 | 2024-12-09 | MRNA | S | 529 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.